Short Description
Quantifies FMO6P protein levels in human tissues, cell lysates, and biological fluids using a sensitive ELISA platform.
ADME Research Domain
Metabolism
Description
MetaVital™ FMO6P ELISA Kit enables precise in vitro quantification of Human Putative Dimethylaniline Monooxygenase [N-oxide-forming] 6 in tissue homogenates, cell lysates, and other biological fluids. Designed for high reproducibility, this colorimetric assay provides reliable measurement across a broad dynamic range for research applications.
Features
High specificity and sensitivity for native human FMO6P detection, minimizing cross-reactivity with other FMO family members.
Colorimetric detection with a quantifiable range from 0.156 ng/mL to 10 ng/mL ensures precise, reproducible measurements.
Lyophilized standards and reagents enhance stability and enable long-term storage with minimal activity loss under controlled conditions.
Optimized for tissue homogenates, cell lysates, and biological fluids, offering flexibility for diverse sample types and research designs.
Process Relevance
Supports accurate monitoring of FMO6P expression to aid pharmacological and toxicological research in human biological systems.
Application Stage
Drug discovery, pathway elucidation, and in vitro biomarker evaluation.
Applications
Quantitative ELISA measurement of FMO6P in human tissue homogenates, cell lysates, and biological fluids for pharmacology, ADME profiling studies, and toxicology studies.
Qualified With
Internal performance validation using reference standards under defined assay conditions.
Target
Human Putative Dimethylaniline Monooxygenase [N-oxide-forming] 6 (FMO6P)
Detection Method
Colorimetric
Sample Type
Tissue homogenates, cell lysates and other biological fluids.
Assay Measures
Quantitative
Research Areas
Pharmacokinetics (ADME), xenobiotic metabolism, drug development, enzymology, human liver biology, toxicology, metabolic pathway analysis, etc.